Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.217302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Niveditha Nerlakanti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, 33612, USA; Department of Tumor Microenvironment & Metastasis, H. Lee Moffitt C…. Hauptthemen laut MEDLINE: Neuropilin-1, Osteosarcoma, Lung Neoplasms, Cell Movement. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
The lungs represent the most common site of metastasis for osteosarcoma (OS). Despite our advances in developing targeted therapies for treating solid malignancies, broad acting chemotherapies remain the first line treatment for OS. In assaying the efficacy of approved therapeutics for non-OS malignancies, we previously identified the histone deacetylase 1 and 2 (HDAC1 and 2) inhibitor, romidepsin, as effective for the treatment of established lung metastatic OS. Yet, romidepsin has noted toxicities in humans and so here we aimed to define the primary mechanisms through which HDAC1/2 mediate OS progression to identify more selective druggable targets/pathways. Microarray and proteomics analyses of romidepsin treated OS cells revealed a significant suppression of neuropilin-1 (NRP1), a known regulator of cancer cell migration and invasion. Silencing of NRP1 significantly reduced OS proliferation, migration, invasion and adhesion in vitro. More strikingly, in vivo, reduced NRP1 expression significantly mitigated the lung metastatic potential of OS in two independent models (K7M2 and SAOS-LM7). Mechanistically, our data point to NRP1 mediating this effect via the down regulation of migration machinery, namely SRC, FAK and ROCK1 expression/activity, that is in part, related to NRP1 interaction with integrin beta 1 (ITGB1). In summary, our data indicate that romidepsin down regulation of NRP1 significantly mitigates the ability of OS cells to seed the lung and establish metastases, and that targeting NRP1 or its effectors with selective inhibitors may be a viable means with which to prevent this deadly aspect of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, 33612, USA; Department of Tumor Microenvironment & Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
- Department of Tumor Microenvironment & Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
- Sarcoma Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA.
- Department of Tumor Microenvironment & Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA. Electronic address: conor.lynch@moffitt.org.
Förderung
- NCI NIH HHS
Zitieren
APA
Nerlakanti, N., McGuire, J. J., Bishop, R. T., Nasr, M. M., Li, T., Reed, D. R., & Lynch, C. C. (2024). Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217302
Vancouver
Nerlakanti N, McGuire JJ, Bishop RT, Nasr MM, Li T, Reed DR, et al. Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217302
BibTeX
@article{Nerlakanti2024,
author = {Nerlakanti, Niveditha and McGuire, Jeremy J and Bishop, Ryan T and Nasr, Mostafa M and Li, Tao and Reed, Damon R and Lynch, Conor C},
title = {Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.217302}
}
EUVIMED